Primary systemic chemotherapy for operable breast cancer with docetaxel followed by cyclophosphamide, epirubicin, and fluorauracil (DOC-CEF)

被引：0
|
作者：
Kikawa, Y.
Masai, Y.
Hashimoto, T.
Nakamoto, Y.
Nishikawa, H.
Takahara, S.
Suwa, H.
Tachibana, T.
机构：
[1] Kobe West City Hosp, Kobe, Hyogo, Japan
[2] Kobe City Gen Hosp, Kobe, Hyogo, Japan
[3] Hyogo Kenritsu Amagasaki Hosp, Amagasaki, Hyogo, Japan
[4] Hyogo Prefectural Tsukaguchi Hosp, Amagasaki, Hyogo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11085
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cyclophosphamide, epirubicin and fluorouracil followed by docetaxel (CEF-DOC) as preoperative chemotherapy in primary operable breast cancer: Evaluation of chemotherapeutic response by breast MRI.
    Nakamura, S
    Ohno, S
    Toi, M
    Takatsuka, Y
    Kuroi, K
    Iwata, H
    Hisamatsu, K
    Yamazaki, K
    Masuda, N
    Akiyama, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 79S - 79S
  • [2] Epirubicin and Cyclophosphamide Followed by Docetaxel as Primary Systemic Chemotherapy in Locally Advanced Breast Cancer
    Hirano, Akira
    Shimizu, Tadao
    Watanabe, Osamu
    Kinoshita, Jun
    Kimura, Kiyomi
    Kamimura, Mari
    Domoto, Kaoru
    Aiba, Motohiko
    Ogawa, Kenji
    [J]. ANTICANCER RESEARCH, 2008, 28 (6B) : 4137 - 4142
  • [3] Primary chemotherapy with sequential docetaxel followed by docetaxel and epirubicin in large operable breast cancer
    Frutuoso, C.
    Henriques, I.
    Pazos, I.
    Abraul, E.
    Pego, A.
    Belo, J.
    Campos, O.
    Gervasio, H.
    De Oliveira, C.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2007, 28 (06) : 447 - 450
  • [4] Docetaxel followed by epirubicin plus docetaxel as primary systemic therapy for large operable breast cancer
    Frutuoso, Cristina
    Henriques, Isabel
    Pazos, Isabel
    Abraul, Elsa
    Pego, Antonio
    Belo, Joana
    Campos, Ondina
    Gervasio, Helena
    De Oliveira, Carlos F.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 66 - 66
  • [5] Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer
    Iwata, Hiroji
    Sato, Nobuaki
    Masuda, Norikazu
    Nakamura, Seigo
    Yamamoto, Naohito
    Kuroi, Katsumasa
    Kurosumi, Masafumi
    Tsuda, Hitoshi
    Akiyama, Futoshi
    Ohashi, Yasuo
    Toi, Masakazu
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 867 - 875
  • [6] Neoadjuvant docetaxel (DOC 75) followed by fluorouracil, epirubicin, cyclophosphamide (FEC 100) in primary operable breast cancer: results of a multicenter phase II trial
    Sato, N.
    Iwata, H.
    Masuda, N.
    Nakamura, S.
    Yamamoto, N.
    Kuroi, K.
    Kurosumi, M.
    Tsuda, H.
    Akiyama, F.
    Toi, M.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 121 - 121
  • [7] Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophosphamide followed by docetaxel in primary breast cancer.
    Cramer, EM
    Moers, C
    Zarghooni, V
    Mallmann, P
    Warm, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 82S - 82S
  • [8] Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer
    Zhang, Minmin
    Wei, Wei
    Liu, Jianlun
    Yang, Huawei
    Jiang, Yi
    Tang, Wei
    Li, Qiuyun
    Liao, Xiaoming
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 3443 - 3450
  • [9] Epirubicin (EPI) and docetaxel (DOC) as primary chemotherapy (PCT) in ≥ 3cm breast cancer
    Conti, F.
    Valerio, M. R.
    Visca, P.
    Sergi, D.
    Masi, M. C.
    Spinnato, F.
    Foggi, P.
    Amodio, A.
    Vitucci, C.
    Gebbia, N.
    Lopez, M.
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 142 - 142
  • [10] Comparison of epirubicin and vinorelbine with cyclophosphamide, epirubicin, and fluorouracil as neoadjuvant chemotherapy for operable breast cancer
    Han, S.
    Kwak, K.
    Kim, J.
    Kim, J.
    Park, K.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 122 - 122
12345